What are the typical plasma sodium levels in patients with Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Plasma Sodium Levels in SIADH

Patients with SIADH typically present with hyponatremia, defined as serum sodium <135 mEq/L, with most clinically significant cases falling below 130-131 mmol/L. 1, 2

Defining Hyponatremia in SIADH

  • Hyponatremia is defined as serum sodium <135 mEq/L, though clinical significance and need for intervention typically begins when levels drop below 130-131 mmol/L 1, 2
  • Moderate hyponatremia ranges from 120-125 mEq/L, requiring more aggressive management 1
  • Severe hyponatremia is defined as serum sodium <120 mEq/L, representing a medical emergency when symptomatic 1, 3

Characteristic Laboratory Findings in SIADH

SIADH is characterized by a specific constellation of laboratory abnormalities that distinguish it from other causes of hyponatremia:

  • Hypotonic hyponatremia with plasma osmolality <275 mOsm/kg 2, 4
  • Inappropriately concentrated urine with osmolality >500 mOsm/kg despite low serum osmolality 2, 4
  • Elevated urinary sodium concentration typically >20-40 mEq/L, often exceeding 40 mEq/L 2, 4
  • Clinical euvolemia (absence of edema, orthostatic hypotension, or signs of volume depletion) 2, 4
  • Normal renal, adrenal, and thyroid function 2, 4

Severity Classification and Clinical Implications

The degree of hyponatremia in SIADH directly correlates with morbidity and mortality:

  • Mild hyponatremia (130-135 mEq/L) is associated with increased fall risk (21% vs 5% in normonatremic patients) and should not be dismissed as clinically insignificant 1
  • Moderate hyponatremia (<130 mEq/L) carries a 60-fold increase in hospital mortality (11.2% vs 0.19%) compared to normonatremic patients 1
  • Severe symptomatic hyponatremia (<120 mEq/L with neurological symptoms) requires immediate intervention with hypertonic saline 1, 2

Urine Studies That Confirm SIADH

Beyond the serum sodium level, specific urine findings are diagnostic:

  • Urine osmolality persistently >100 mOsm/kg (typically >500 mOsm/kg) indicates impaired water excretion 2, 4
  • Urine sodium concentration >20-40 mEq/L reflects physiologic natriuresis occurring to maintain fluid balance at the expense of plasma sodium 2, 4
  • Very high urine sodium concentrations (>130 mmol/L) can occur in severe SIADH and predict poor response to fluid restriction 5
  • Serum uric acid <4 mg/dL has a positive predictive value of 73-100% for SIADH 1

Common Pitfalls in Diagnosis

  • Failing to distinguish SIADH from cerebral salt wasting (CSW) in neurosurgical patients is critical, as CSW presents with hypovolemia (CVP <6 cm H₂O) despite similar urine sodium levels, requiring opposite treatment approaches 1, 2
  • Ignoring mild hyponatremia (130-135 mEq/L) as clinically insignificant overlooks the increased risk of falls, cognitive impairment, and mortality 1
  • Assuming all patients with high urine sodium have SIADH without confirming euvolemia and excluding other causes like diuretic use or renal salt wasting 1

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The treatment of severe hyponatremia.

Kidney international. Supplement, 1998

Research

[Hyponatremia secondary to inappropriate antidiuretic hormone secretion].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.